相关实验视频
Updated: Jun 28, 2025

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
在慢性阻塞性肺病的临床稳定性和恶化的细菌相互作用干扰
Wei Xiao1,2, Yi-Long Chen3,4, Long-Yi Du1
1Division of Pulmonary Medicine, Department of Internal Medicine, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital of Sichuan University, No. 37, Guoxue Lane, Wuhou District, Chengdu, 610041, China.
减少的负面细菌相互作用是慢性阻塞性肺病 (COPD) 中呼吸道失调的特征. 这种微生物相互作用干扰,而不是病原体的丰富性,与疾病的严重程度和恶化有关.
科学领域:
- 微生物组研究的研究.
- 呼吸系统药物 呼吸系统药物
- 系统生物学 系统生物学
背景情况:
- 慢性阻塞性肺病 (COPD) 的呼吸道失调并未完全被理解.
- 调查微生物相互作用 (互动组) 可能会澄清COPD的发病原因.
研究的目的:
- 在COPD中描述呼吸道细菌相互作用体的稳定特征.
- 评估COPD恶化期间的相互作用变化.
- 与COPD表型相关联互动组特征.
主要方法:
- 基于组合的权重共发生网络分析.
- 综合了来自各种COPD研究的1742个唾液微生物组.
- 分析了稳定的COPD,恶化和恢复阶段.
主要成果:
- 与对照组相比,COPD患者的负面细菌相互作用减少.
- 在COPD中改变了Haemophilus的敌对相互作用网络,而不是丰富性.
- 恶化特征减少了对抗性相互作用,这些相互作用在治疗后恢复.
- 对抗性相互作用的丧失与症状恶化,肺功能,炎症和恶化风险相关.
结论:
- 减少对抗性细菌相互作用是COPD呼吸道失调的一个标志.
- 这种相互作用干扰发生在稳定和恶化期间.
- 针对微生物互动组,而不仅仅是病原体,可能为COPD提供新的治疗策略.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids

